The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

NVS FINANCIAL STATEMENTS

Novartis AG ADR — balance sheet, income statement and cash flow trends

NVSNovartis AG ADR

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
020 B40 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue55.6 B $Gross Profit41.4 B $ · 74%Operating Income17 B $ · 31%Pre-tax Income15.5 B $ · 28%Net Income to Owners12.8 B $ · 23%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue55.6 B $+0.8%
Gross Profit41.4 B $-1.6%
Operating Income17 B $+1.8%
EBITDA22.3 B $-2.0%
Net Income to Owners12.8 B $-6.6%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 B100 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets122 B
  • Equity41.5 B $34%
  • Current Liabilities31.7 B $26%
  • Long-term Liabilities48.3 B $40%

Key Figures

YoY change
Total Assets122 B $+16.9%
Total Liabilities80.1 B $+28.5%
Total Equity41.5 B $-1.1%
Cash & ST Investments7.7 B $+9.9%
Total Debt49 B $+50.2%
Net Debt41.4 B $+59.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
010 B20 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
010 B18.4 B $Operating-17.8 B $Investing472.2 M $Financing1.1 B $Net Change

Key Figures

YoY change
Operating Cash Flow18.4 B $-11.5%
Capital Expenditures2.6 B $-35.5%
Free Cash Flow15.8 B $-5.9%
Dividends Paid9.1 B $-41.1%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NVS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.